Dan Ferry
LifeSci Advisors
Replay available
Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Marcio Souza
President and Chief Executive Officer
Tim Kelly
Chief Financial Officer
Yasmine Rahimi
Analyst, Piper Sandler
Ritu Baral
Analyst, TD Cal
Tiago Faust
Analyst, Raymond James
Francois Brisebois
Analyst, LifeSite Capital
Yatin Suneha
Analyst, Guggenheim
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Praxis Precision Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.694 Good day, ladies and gentlemen, and thank you for standing by. 00:00:02.694 -- 00:00:07.880 Welcome to the Praxis Precision Medicine's first quarter 2026 financial 00:00:07.880 -- 00:00:12.905 results conference call. At this time, all participants are in a listen-only mode. 00:00:12.905 -- 00:00:16.589 After the speaker's presentation, there will be a question and answer session. 00:00:16.589 -- 00:00:21.815 To ask a question, you will need to press star 11 on your telephone keypad. 00:00:21.815 -- 00:00:24.601 As a reminder, this conference call is being recorded. 00:00:24.601 -- 00:00:27.244 At this time, I would like to turn the conference over to Mr. 00:00:27.244 -- 00:00:32.488 Dan Ferry of LifeSci Advisors. Sir, please begin. 00:00:32.651 -- 00:00:38.017 Good morning, and welcome to Praxis Precision Medicine's first quarter 2026 financial 00:00:38.017 -- 00:00:41.181 results and business update conference call. 00:00:41.181 -- 00:00:45.687 This call is being webcast live and can be accessed on the investor section of Praxis' 00:00:45.687 -- 00:00:49.729 website at www.praxismedicines.com. 00:00:50.593 -- 00:00:54.740 Please note that remarks made during this call may contain forward-looking statements. 00:00:54.740 -- 00:00:59.425 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:59.425 -- 00:01:03.488 These may include statements about the company's future expectations and plans, clinical 00:01:03.488 -- 00:01:07.530 development timelines, and financial projections. 00:01:07.993 -- 00:01:12.337 While these forward-looking statements represent Praxis's views as of today, they should 00:01:12.337 -- 00:01:16.461 not be relied upon as representing the company's views in the future. 00:01:16.461 ...